Skip to main content
. Author manuscript; available in PMC: 2012 Mar 15.
Published in final edited form as: Int J Cancer. 2011 Mar 15;128(6):1404–1413. doi: 10.1002/ijc.25434

TABLE 5.

Adjusted odds ratios (ORs) and 95% confidence intervals (CIs) for non-small cell lung cancer stratified by smoking status

Never Former Current
Cases/controls OR1 (95% CI) Cases/controls OR1 (95% CI) Cases/controls OR1 (95% CI) P-interaction

Age at menarche
 <12 8/33 1.00 (Reference) 32/40 1.00 (Reference) 45/36 1.00 (Reference)
 12-13 25/111 0.87 (0.33, 2.28) 83/146 0.65 (0.37, 1.14) 115/79 1.16 (0.67, 2.01)
 14-15 7/33 1.02 (0.30, 3.51) 33/46 0.74 (0.37, 1.47) 52/44 0.83 (0.45, 1.55)
 ≥16 2/4 0.84 (0.10, 6.81) 13/25 0.56 (0.24, 1.32) 15/14 0.80 (0.33, 1.94) 0.77
Menopausal status2
 Natural menopause at age <50 7/22 1.35 (0.37, 4.92) 32/42 1.32 (0.67, 2.60) 68/35 1.67 (0.86, 3.24)
 Natural menopause at age 50-54 7/44 1.00 (Reference) 29/53 1.00 (Reference) 32/32 1.00 (Reference)
 Natural menopause at age ≥55 4/13 2.09 (0.47, 9.26) 20/28 1.32 (0.61, 2.85) 5/10 0.45 (0.13, 1.52) 0.15
Number of live births
 Nulliparous 9/19 1.65 (0.54, 5.04) 17/25 1.04 (0.50, 2.18) 19/15 1.12 (0.52, 2.42)
 1-2 6/48 1.00 (Reference) 40/86 1.00 (Reference) 99/68 1.00 (Reference)
 3-4 14/69 0.62 (0.23, 1.65) 63/97 0.68 (0.42, 1.10) 73/64 0.71 (0.43, 1.16)
 ≥ 5 13/45 0.26 (0.06, 1.07) 41/49 0.48 (0.24, 0.99) 36/26 0.54 (0.28, 1.05) 0.58
Age at first birth
 Nulliparous 9/19 3.11 (0.78, 12.31) 17/25 1.70 (0.77, 3.76) 19/15 1.10 (0.50, 2.42)
 <20 20/72 1.00 (Reference) 74/104 1.00 (Reference) 114/78 1.00 (Reference)
 20-24 10/56 1.32 (0.43, 4.07) 54/90 1.34 (0.78, 2.30) 66/54 0.69 (0.42, 1.13)
 ≥25 3/34 1.88 (0.57, 6.17) 16/38 1.67 (0.88, 3.18) 28/26 0.83 (0.43, 1.57) 0.13
Age at last birth
 Nulliparous 9/19 1.37 (0.34, 5.61) 17/25 1.27 (0.58, 2.78) 19/15 1.12 (0.51, 2.47)
 <25 7/27 1.00 (Reference) 39/73 1.00 (Reference) 81/57 1.00 (Reference)
 25-29 13/56 0.76 (0.23, 2.46) 51/62 1.37 (0.77, 2.42) 64/48 0.83 (0.49, 1.41)
 ≥30 13/79 0.49 (0.15, 1.59) 54/97 0.69 (0.39, 1.22) 63/53 0.71 (0.42, 1.20) 0.53
Oral contraception
 Never user 21/97 1.00 (Reference) 99/142 1.00 (Reference) 114/87 1.00 (Reference)
 Ever user 21/84 1.71 (0.66, 4.45) 62/115 1.24 (0.76, 2.02) 113/86 1.22 (0.77, 1.92) 0.62
Menopausal hormone therapy
 Never used 18/85 1.00 (Reference) 80/121 1.00 (Reference) 138/94 1.00 (Reference)
 Ever used 24/96 1.42 (0.62, 3.26) 81/136 0.95 (0.61, 1.47) 89/79 0.88 (0.57, 1.35) 0.72
 Ever used estrogen plus progestin pills3 3/9 1.74 (0.34, 8.82) 11/18 1.20 (0.49, 2.94) 7/5 1.09 (0.32, 3.69) 0.83
 Ever used estrogen pills3,4 7/34 0.31 (0.05, 2.03) 25/46 0.78 (0.35, 1.74) 34/34 0.72 (0.35, 1.49) 0.64
1

Conditioned on age and race and adjusted for age, education, smoking, number of smoking adults in household, current household income

2

Also adjusted for premenopause, hysterectomy/ovaries removed, hysterectomy/ovaries removed or unknown if ovaries removed, other reasons for having menopause

3

Excludes women who reported ever using a different type of menopausal hormone therapy

4

Among women who ever had a hysterectomy (n=434); reference group is 6/23 never smokers, 25/46 former smokers, and 46/30 current smokers who never used menopausal hormones